Firmenbeschreibung
Moderna Inc. ist ein US amerikanisches Biotech-Unternehmen, das sich auf die Forschung und Entwicklung von Arzneimitteln auf Basis von mRNA spezialisiert. mRNA-Arzneien sind darauf ausgelegt, dass körpereigene Zellen Proteine mit therapeutischer oder vorbeugender Wirkung produzieren, die bei der Behandlung einer Vielzahl von Krankheiten helfen können. Die Anwendungsgebiete für mRNA-Produkte umfassen Therapeutika und Impfstoffe für Krebsimmuntherapien, seltene Krankheiten, Herz-Kreislauf-Erkrankungen, Autoimmunerkrankungen und Entzündungen. Die beständigen Fortschritte des Unternehmens in der Grundlagen- und angewandten mRNA-Forschung ermöglichen parallele Neuentwicklungen, sowohl unabhängig als auch mit strategischen Partnern zusammen. Es bestehen strategische Partnerschaften mit AstraZeneca PLC und Merck & Co., außerdem mit verschiedenen US-Behörden und Forschungseinrichtungen.
KeyData
| endOfFinancialYear: | 31.12.2024 00:00 |
| stockholderStructure: | BAILLIE GIFFORD CO (11.9128%),Vanguard Group (8.84748%),BlackRock Inc. (6.60205%),State Street Corporation (3.81582%),Flagship Pioneering Inc. (2.52219%),Theleme Partners LLP (1.91772%),Wellington Management Group (1.88539%),GEODE CAPITAL MANAGEMENT LLC (1.70897%),FMR LLC. (1.66824%),Goldman Sachs Group Inc. (1.18767%) |
| sharesOutstanding: | 384396030.0000 |
| ceo: | Stéphane Bancel |
| board: | Jamey Mock, Stephen Hoge, M.D., Jerh Collins, Ph.D., Kate Cronin, Tracey Franklin, Shannon Thyme Klinger, Brad Miller |
| supervisoryBoard: | Dr. Noubar Afeyan, Stéphane Bancel, Sandra Horning, M.D., Abbas Hussain, Elizabeth Nabel, M.D., François Nader, M.D., David Rubenstein, Paul Sagan, Elizabeth Tallett, Henri A. Termeer |
| countryID: | 20 |
| faceValue: | 0.0001 |
| faceValueCurrencyID: | 4 |
| faceValueCurrency: | USD |
| sectorName: | Biotechnologie |
| industryName: | Biotechnologie |
| subsectorName: | Biotechnologie |
| country: | USA |
| countryName: | USA |
Kontakt
| email: | IR@modernatx.com |
| irWebSite: | https://investors.modernatx.com/ |
Adresse
| street: | 200 Technology Square |
| city: | Cambridge, Massachusetts 02139, USA |
| phone: | +1-617-714-6500 |
| fax: | +1-617-583-1998 |
| webSite: | https://www.modernatx.com/ |
| email: | info@modernatx.com |
Finanzen (kurz)
| year: | 2021 | cash: | 6848.0000 |
| balanceSheetTotal: | 24669.0000 | liabilities: | 10524.0000 |
| totalShareholdersEquity: | 14145.0000 | sales: | 18471.0000 |
| investment: | 18.0000 | incomeBeforeTaxes: | 13285.0000 |
| netIncome: | 12202.0000 | cashFlow: | 4224.0000 |
| employees: | 2700 | currencyID: | 4 |
| units: | 1000000 | currency: | USD |
| year: | 2022 | cash: | 3205.0000 |
| balanceSheetTotal: | 25858.0000 | liabilities: | 6735.0000 |
| totalShareholdersEquity: | 19123.0000 | sales: | 19263.0000 |
| incomeBeforeTaxes: | 9575.0000 | netIncome: | 8362.0000 |
| cashFlow: | -3643.0000 | currencyID: | 4 |
| units: | 1000000 | currency: | USD |
| year: | 2023 | cash: | 2907.0000 |
| balanceSheetTotal: | 18426.0000 | liabilities: | 4572.0000 |
| shareCapital: | 0.0000 | totalShareholdersEquity: | 13854.0000 |
| sales: | 6848.0000 | incomeBeforeTaxes: | -3942.0000 |
| netIncome: | -4714.0000 | cashFlow: | -289.0000 |
| currencyID: | 4 | units: | 1000000 |
| currency: | USD |
Finanzen (kurz)
| year: | 2021 |
| cash: | 6848.0000 |
| balanceSheetTotal: | 24669.0000 |
| liabilities: | 10524.0000 |
| totalShareholdersEquity: | 14145.0000 |
| sales: | 18471.0000 |
| investment: | 18.0000 |
| incomeBeforeTaxes: | 13285.0000 |
| netIncome: | 12202.0000 |
| cashFlow: | 4224.0000 |
| employees: | 2700 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
| year: | 2022 |
| cash: | 3205.0000 |
| balanceSheetTotal: | 25858.0000 |
| liabilities: | 6735.0000 |
| totalShareholdersEquity: | 19123.0000 |
| sales: | 19263.0000 |
| incomeBeforeTaxes: | 9575.0000 |
| netIncome: | 8362.0000 |
| cashFlow: | -3643.0000 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
| year: | 2023 |
| cash: | 2907.0000 |
| balanceSheetTotal: | 18426.0000 |
| liabilities: | 4572.0000 |
| shareCapital: | 0.0000 |
| totalShareholdersEquity: | 13854.0000 |
| sales: | 6848.0000 |
| incomeBeforeTaxes: | -3942.0000 |
| netIncome: | -4714.0000 |
| cashFlow: | -289.0000 |
| currencyID: | 4 |
| units: | 1000000 |
| currency: | USD |
Finanzen (ausführlich)
| year: | 2022 | units: | 1000000 |
| balanceSheetTotal: | 25858.0000 | cash: | 3205.0000 |
| currentAssets: | 13431.0000 | fixedAssets: | 12427.0000 |
| liabilities: | 4923.0000 | totalLiabilitiesEquity: | 25858.0000 |
| totalShareholdersEquity: | 19123.0000 | property: | 2018.0000 |
| longTermInvestments: | 8318.0000 | inventories: | 949.0000 |
| accountsReceivable: | 1385.0000 | accountsPayable: | 487.0000 |
| liabilitiesTotal: | 6735.0000 | longTermDebt: | 912.0000 |
| sales: | 19263.0000 | netIncome: | 8362.0000 |
| operatingResult: | 9420.0000 | incomeInterest: | 200.0000 |
| investments: | 3295.0000 | incomeTaxes: | 1213.0000 |
| costGoodsSold: | 5416.0000 | grossProfit: | 13847.0000 |
| cashFlow: | 4981.0000 | cashFlowInvesting: | -5176.0000 |
| cashFlowFinancing: | -3448.0000 | cashFlowTotal: | -3643.0000 |
| accountingStandard: | US GAAP | equityRatio: | 73.9539 |
| debtEquityRatio: | 0.0477 | liquidityI: | 0.6510 |
| liquidityII: | 0.9324 | netMargin: | 43.4096 |
| grossMargin: | 71.8839 | cashFlowMargin: | 25.8579 |
| ebitMargin: | 48.9020 | ebitdaMargin: | 0.0000 |
| preTaxROE: | 50.0706 | preTaxROA: | 37.0292 |
| roe: | 43.7274 | roa: | 32.3382 |
| netIncomeGrowth: | -31.4703 | revenuesGrowth: | 4.2878 |
| taxExpenseRate: | 12.6684 | equityTurnover: | 1.0073 |
| epsBasic: | 21.2600 | epsDiluted: | 20.1200 |
| epsBasicGrowth: | -29.8581 | incomeBeforeTaxes: | 9575.0000 |
| priceEarningsRatioCompany: | 8.4487 | priceCashFlowRatio: | 13.9318 |
| bookValuePerShare: | 49.4979 | marketCap: | 69394317874.2800 |
| earningsYield: | 11.8361 | pegRatio: | -0.2830 |
| cashFlowPerShare: | 12.8928 | priceBookValueRatio: | 3.6288 |
| priceEarningsRatio: | 8.2988 | netEarningsPerShare: | 21.6442 |
| currency: | USD |
| year: | 2023 | units: | 1000000 |
| balanceSheetTotal: | 18426.0000 | cash: | 2907.0000 |
| currentAssets: | 10325.0000 | fixedAssets: | 8101.0000 |
| liabilities: | 3015.0000 | totalLiabilitiesEquity: | 18426.0000 |
| totalShareholdersEquity: | 13854.0000 | property: | 1945.0000 |
| longTermInvestments: | 4677.0000 | inventories: | 202.0000 |
| accountsReceivable: | 892.0000 | accountsPayable: | 520.0000 |
| liabilitiesTotal: | 4572.0000 | longTermDebt: | 575.0000 |
| commonStock: | 0.0000 | preferredStock: | 0.0000 |
| sales: | 6848.0000 | netIncome: | -4714.0000 |
| operatingResult: | -4239.0000 | incomeInterest: | 421.0000 |
| investments: | 4845.0000 | incomeTaxes: | 772.0000 |
| costGoodsSold: | 4693.0000 | grossProfit: | 2155.0000 |
| cashFlow: | -3118.0000 | cashFlowInvesting: | 4206.0000 |
| cashFlowFinancing: | -1377.0000 | cashFlowTotal: | -289.0000 |
| accountingStandard: | US GAAP | equityRatio: | 75.1872 |
| debtEquityRatio: | 0.0415 | liquidityI: | 0.9642 |
| liquidityII: | 1.2600 | netMargin: | -68.8376 |
| grossMargin: | 31.4690 | cashFlowMargin: | -45.5315 |
| ebitMargin: | -61.9013 | ebitdaMargin: | 0.0000 |
| preTaxROE: | -28.4539 | preTaxROA: | -21.3937 |
| roe: | -34.0263 | roa: | -25.5834 |
| netIncomeGrowth: | -156.3741 | revenuesGrowth: | -64.4500 |
| taxExpenseRate: | -19.5840 | equityTurnover: | 0.4943 |
| epsBasic: | -12.3300 | epsDiluted: | -12.3300 |
| epsBasicGrowth: | -157.9962 | shareCapital: | 0.0000 |
| incomeBeforeTaxes: | -3942.0000 | priceCashFlowRatio: | -12.1864 |
| bookValuePerShare: | 36.2601 | marketCap: | 37997180535.6000 |
| earningsYield: | -12.3982 | cashFlowPerShare: | -8.1607 |
| priceBookValueRatio: | 2.7427 | netEarningsPerShare: | -12.3379 |
| currency: | USD |
| year: | 2024 | priceCashFlowRatio: | -7.2383 |
| bookValuePerShare: | 36.2601 | marketCap: | 22706273492.1000 |
| earningsYield: | -20.8735 | pegRatio: | 0.0303 |
| cashFlowPerShare: | -8.1607 | netAssetsPerShare: | 36.2601 |
| priceBookValueRatio: | 1.6291 | netEarningsPerShare: | -12.3379 |
| currency: | USD |
Finanzen (ausführlich)
| year: | 2022 |
| units: | 1000000 |
| balanceSheetTotal: | 25858.0000 |
| cash: | 3205.0000 |
| currentAssets: | 13431.0000 |
| fixedAssets: | 12427.0000 |
| liabilities: | 4923.0000 |
| totalLiabilitiesEquity: | 25858.0000 |
| totalShareholdersEquity: | 19123.0000 |
| property: | 2018.0000 |
| longTermInvestments: | 8318.0000 |
| inventories: | 949.0000 |
| accountsReceivable: | 1385.0000 |
| accountsPayable: | 487.0000 |
| liabilitiesTotal: | 6735.0000 |
| longTermDebt: | 912.0000 |
| sales: | 19263.0000 |
| netIncome: | 8362.0000 |
| operatingResult: | 9420.0000 |
| incomeInterest: | 200.0000 |
| investments: | 3295.0000 |
| incomeTaxes: | 1213.0000 |
| costGoodsSold: | 5416.0000 |
| grossProfit: | 13847.0000 |
| cashFlow: | 4981.0000 |
| cashFlowInvesting: | -5176.0000 |
| cashFlowFinancing: | -3448.0000 |
| cashFlowTotal: | -3643.0000 |
| accountingStandard: | US GAAP |
| equityRatio: | 73.9539 |
| debtEquityRatio: | 0.0477 |
| liquidityI: | 0.6510 |
| liquidityII: | 0.9324 |
| netMargin: | 43.4096 |
| grossMargin: | 71.8839 |
| cashFlowMargin: | 25.8579 |
| ebitMargin: | 48.9020 |
| ebitdaMargin: | 0.0000 |
| preTaxROE: | 50.0706 |
| preTaxROA: | 37.0292 |
| roe: | 43.7274 |
| roa: | 32.3382 |
| netIncomeGrowth: | -31.4703 |
| revenuesGrowth: | 4.2878 |
| taxExpenseRate: | 12.6684 |
| equityTurnover: | 1.0073 |
| epsBasic: | 21.2600 |
| epsDiluted: | 20.1200 |
| epsBasicGrowth: | -29.8581 |
| incomeBeforeTaxes: | 9575.0000 |
| priceEarningsRatioCompany: | 8.4487 |
| priceCashFlowRatio: | 13.9318 |
| bookValuePerShare: | 49.4979 |
| marketCap: | 69394317874.2800 |
| earningsYield: | 11.8361 |
| pegRatio: | -0.2830 |
| cashFlowPerShare: | 12.8928 |
| priceBookValueRatio: | 3.6288 |
| priceEarningsRatio: | 8.2988 |
| netEarningsPerShare: | 21.6442 |
| currency: | USD |
| year: | 2023 |
| units: | 1000000 |
| balanceSheetTotal: | 18426.0000 |
| cash: | 2907.0000 |
| currentAssets: | 10325.0000 |
| fixedAssets: | 8101.0000 |
| liabilities: | 3015.0000 |
| totalLiabilitiesEquity: | 18426.0000 |
| totalShareholdersEquity: | 13854.0000 |
| property: | 1945.0000 |
| longTermInvestments: | 4677.0000 |
| inventories: | 202.0000 |
| accountsReceivable: | 892.0000 |
| accountsPayable: | 520.0000 |
| liabilitiesTotal: | 4572.0000 |
| longTermDebt: | 575.0000 |
| commonStock: | 0.0000 |
| preferredStock: | 0.0000 |
| sales: | 6848.0000 |
| netIncome: | -4714.0000 |
| operatingResult: | -4239.0000 |
| incomeInterest: | 421.0000 |
| investments: | 4845.0000 |
| incomeTaxes: | 772.0000 |
| costGoodsSold: | 4693.0000 |
| grossProfit: | 2155.0000 |
| cashFlow: | -3118.0000 |
| cashFlowInvesting: | 4206.0000 |
| cashFlowFinancing: | -1377.0000 |
| cashFlowTotal: | -289.0000 |
| accountingStandard: | US GAAP |
| equityRatio: | 75.1872 |
| debtEquityRatio: | 0.0415 |
| liquidityI: | 0.9642 |
| liquidityII: | 1.2600 |
| netMargin: | -68.8376 |
| grossMargin: | 31.4690 |
| cashFlowMargin: | -45.5315 |
| ebitMargin: | -61.9013 |
| ebitdaMargin: | 0.0000 |
| preTaxROE: | -28.4539 |
| preTaxROA: | -21.3937 |
| roe: | -34.0263 |
| roa: | -25.5834 |
| netIncomeGrowth: | -156.3741 |
| revenuesGrowth: | -64.4500 |
| taxExpenseRate: | -19.5840 |
| equityTurnover: | 0.4943 |
| epsBasic: | -12.3300 |
| epsDiluted: | -12.3300 |
| epsBasicGrowth: | -157.9962 |
| shareCapital: | 0.0000 |
| incomeBeforeTaxes: | -3942.0000 |
| priceCashFlowRatio: | -12.1864 |
| bookValuePerShare: | 36.2601 |
| marketCap: | 37997180535.6000 |
| earningsYield: | -12.3982 |
| cashFlowPerShare: | -8.1607 |
| priceBookValueRatio: | 2.7427 |
| netEarningsPerShare: | -12.3379 |
| currency: | USD |
| year: | 2024 |
| priceCashFlowRatio: | -7.2383 |
| bookValuePerShare: | 36.2601 |
| marketCap: | 22706273492.1000 |
| earningsYield: | -20.8735 |
| pegRatio: | 0.0303 |
| cashFlowPerShare: | -8.1607 |
| netAssetsPerShare: | 36.2601 |
| priceBookValueRatio: | 1.6291 |
| netEarningsPerShare: | -12.3379 |
| currency: | USD |
